Today IBM press published the story of how Caris Life Sciences built its advanced cancer molecular profiling platform based on IBM HPC and Genomics solution.
I was cited in the story:
In a companion blog post by Dr. George Poste of Caris Life Sciences, he explains the details of cancer molecular tumor profiling.
I was cited in the story:
“Precision cancer diagnosis and treatment requires the ability to process and analyze staggering amounts of genomic and other clinical data with scale and speed, and to accelerate this work, we need to provide clinicians and analysts with technical computing platforms,” said Frank N. Lee, Ph.D., Lead Architect, Genomic Medicine, IBM. “IBM technology has helped Caris handle this data volume with greater speed, efficiency and scalability, and at the same time maintain the required security and reliability essential for handling medical and health data.”The press release can be found on IBM.com
In a companion blog post by Dr. George Poste of Caris Life Sciences, he explains the details of cancer molecular tumor profiling.
